POSTER_MBA, CLIA, EIA Borrelia_Comparison of methods for determining Borrelia antibodies.pdf (pdf - 2117 kB) POSTER_MBA multiplex diagnostics of antinuclear antibodies in microtiter plate format (Czech republic).pdf (pdf - 450 kB) POSTER_MBA ANA_A comparative study of MBA with conventional routine methods for the detection of antibodies associated with SLE and Scl in Czech population (Czech Republic, 2024).pdf (pdf - 673 kB) POSTER_MBA ANA_Assessment of the possible role of Micro-Array testing in the diagnostics flow-chart of a specialist referral laboratory for autoimmune diseases (Italy, 2024).pdf (pdf - 291 kB) POSTER_MBA ANA_ICAP classification patterns under magnifying glass of multiplex antibodies detections (Romania,2024).pdf (pdf - 545 kB) POSTER_MBA Borrelia_Microarray immunoblot in the diagnosis of pediatric Lyme neuroborreliosis (Czech Rebublic).pdf (pdf - 2022 kB) POSTER_MBA Borrelia_(Hungarian).pdf (pdf - 1397 kB) Correlation between COVID-19 severity and previous exposure of patients to Borrelia spp. (Poland, 2022).pdf (pdf - 3413 kB) Antibodies to NCP, RBD and S2 SARS-CoV-2 in Vaccinated and Unvaccinated HealthcareWorkers (Poland, 2022).pdf (pdf - 937 kB) Clinical outcomes, immunogenicity, and safety of BNT162b22 Vaccine in Primary Antibody Deficiency (Czech Republic, 2022).pdf (pdf - 8707 kB) COVID-19 in a patient with neuroendocrine pancreatic cancer - Case report (Poland, 2022).pdf (pdf - 361 kB) Dynamics of anti-SARS-CoV-2 seroconversion in individual patients at the population level (Poland, 2022).pdf (pdf - 1217 kB) Hidden fraction of Polish population immumne to SARS-CoV-2 in May 2021 (Poland, 2022).pdf (pdf - 1265 kB) Immune response to COVID-19 mRNA Vaccine - A Pilot Study (Poland, 2021).pdf (pdf - 1483 kB) Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF patients (Czech Republic, 2021).pdf (pdf - 596 kB) Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients (Czech Republic, 2021).pdf (pdf - 627 kB) Impaired Humoral Response to Third Dose of BNT162b2 mRNA COVID-19 Vaccine Despite Detectable Spike Protein-specific T cells in Lung Transplant Recipients (Czech Republic, 2021).pdf (pdf - 395 kB) Dynamics and correlation with commercial serologic tests (Belgium, 2021).pdf (pdf - 394 kB) Relationship between Humoral Response in COVID-19 and Seasonal Influenza Vaccination (Poland, 2022).pdf (pdf - 399 kB) SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors (Czech Republic, 2021).pdf (pdf - 4336 kB) A systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients (USA, 2022).pdf (pdf - 3256 kB) Antibody Tests May Be Widely Accepted (China, 2022).pdf (pdf - 586 kB) Humoral Response after SARS-CoV-2 Vaccination in Prostate Cancer Patients (Poland, 2023).pdf (pdf - 1497 kB) IgG autoantibodies against ACE2 in SARS-CoV-2 infected patients (Poland, 2022).pdf (pdf - 629 kB) Postvaccination Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine and Its Predictors in Pediatric Inflammatory Bowel Diseas (Czech Republic, 2023).pdf (pdf - 548 kB) SARS antibody NCP, RBD and S2 in women vaccinated with booster Pfizer Vaccine and infected in meantime with SARS-CoV-2 (Poland, 2022).pdf (pdf - 376 kB) SARS-CoV-2 specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressive patients (Czech Republic, 2022).pdf (pdf - 3217 kB) SARS-CoV-2 Viral Load Assessment in Lung Transplantation (Czech Republic, 2021).pdf (pdf - 839 kB) Antibody Response after SARS-CoV-2 Infection with the Delta and Omicron Variant (Poland, 2022).pdf (pdf - 1187 kB) Association between the Seroprevalence of Antibodies against Seasonal coronaviruses and SARS-CoV-2 (Poland, 2023).pdf (pdf - 672 kB) Influenza vaccination as a prognostic factor of humoral IgA responses to SARS-CoV-2 infection (MBA_2024, Poland).pdf (pdf - 170 kB) SARS Antibodies NCP, RBD and S2 in Women Vaccinated with Booster Pfizer Vaccine and infected in meantime with SARS-CoV-2 (Poland, 2022).pdf (pdf - 593 kB) Humoral_response_after_breakthrough_SARS-CoV-2_inf.pdf (pdf - 1481 kB) Humoral anti-SARS-CoV-2 response in patients with different long COVID phenotypes (Poland, 2024).pdf (pdf - 1216 kB) Can the Epstein–Barr Virus Play a Role in the Development of Prostate Cancer? (Poland, 2024).pdf (pdf - 1361 kB) Serum Anti-Zta and Anti-LMP1 Antibodies in Oropharyngeal Cancer Related to Epstein–Barr Virus—Diagnostic Usefulness (Poland, 2024).pdf (pdf - 2011 kB) Could MMP3 and MMP9 serve as biomarkers in EBV-related oropharyngeal cancer (MBA_2024, Poland).pdf (pdf - 2468 kB) Serum TLR2 and TLR9 in Prostate Cancer Patients in Relation to EBV Status (Poland, 2024).pdf (pdf - 5275 kB) TestLine publications_31.10.2024.pdf (pdf - 639 kB)